iShares Trust (IBRN)
Management Company · ARCX · Series S000076483 · View on SEC EDGAR ↗
Aug. 24, 2022
Inception
Net flows (30d): +$1.9M Estimated from creation/redemption of shares outstanding
- Net assets
- $5.2M
- Holdings
- 84
- As of
- April 30, 2026 stale
- Expense ratio
- 0.47% (Moderate)
- Top 10 holdings weight
- 45.44%
- Effective number of positions
- 28.2
- Positions above 1%
- 29
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Recent changes Positions the fund added, trimmed or exited most recently.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$0
- Quarter ending Apr 2026
- +$0
- Trailing 12 months
- +$0
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 84 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | $444K | 8.57 | 443,378 | STIV | US |
| Xenon Pharmaceuticals Inc | 98420N105 | $248K | 4.79 | 4,419 | EC | CA |
| AXSOME THERAPEUTICS, INC. | 05464T104 | $238K | 4.59 | 1,144 | EC | US |
| ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | $228K | 4.41 | 3,103 | EC | US |
| ALKERMES PUBLIC LIMITED COMPANY | G01767105 | $217K | 4.20 | 6,446 | EC | IE |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | $204K | 3.95 | 5,186 | OTHER | GB |
| argenx SE | 04016X101 | $201K | 3.88 | 257 | OTHER | NL |
| PTC THERAPEUTICS, INC. | 69366J200 | $191K | 3.69 | 2,938 | EC | US |
| NEUROCRINE BIOSCIENCES, INC. | 64125C109 | $191K | 3.68 | 1,448 | EC | US |
| BIOGEN INC. | 09062X103 | $190K | 3.67 | 1,004 | EC | US |
| Scholar Rock Holding Corp | 80706P103 | $190K | 3.67 | 4,075 | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | $189K | 3.66 | 594 | EC | US |
| ACADIA PHARMACEUTICALS INC. | 004225108 | $187K | 3.61 | 8,328 | EC | US |
| Dianthus Therapeutics Inc | 252828108 | $175K | 3.39 | 1,998 | EC | US |
| CATALYST PHARMACEUTICALS, INC. | 14888U101 | $170K | 3.29 | 6,048 | EC | US |
| Denali Therapeutics Inc | 24823R105 | $146K | 2.82 | 7,800 | EC | US |
| SUPERNUS PHARMACEUTICALS, INC. | 868459108 | $144K | 2.78 | 3,000 | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | $131K | 2.53 | 4,232 | EC | US |
| Dyne Therapeutics, Inc | 26818M108 | $122K | 2.36 | 6,966 | EC | US |
| AxoGen, Inc. | 05463X106 | $121K | 2.34 | 2,800 | EC | US |
| SAREPTA THERAPEUTICS, INC. | 803607100 | $114K | 2.21 | 5,480 | EC | US |
| SK Biopharmaceuticals Co Ltd | Y806MN108 | $106K | 2.04 | 1,547 | EC | KR |
| H. LUNDBECK A/S | — | $99K | 1.92 | 14,762 | EC | DK |
| Capricor Therapeutics Inc | 14070B309 | $90K | 1.75 | 2,693 | EC | US |
| Taysha Gene Therapies Inc | 877619106 | $79K | 1.53 | 12,369 | EC | US |
| BioArctic AB | — | $71K | 1.37 | 2,026 | EC | SE |
| Biohaven Ltd | G1110E107 | $67K | 1.30 | 7,016 | EC | VG |
| Neuren Pharmaceuticals Ltd | — | $55K | 1.06 | 6,016 | EC | NZ |
| Rapport Therapeutics Inc | 75383L102 | $53K | 1.03 | 1,610 | EC | US |
| Dynavox Group AB | — | $48K | 0.94 | 5,451 | EC | SE |
| Bright Minds Biosciences Inc | 10919W405 | $47K | 0.92 | 539 | EC | CA |
| Idorsia Ltd | — | $45K | 0.87 | 9,565 | EC | CH |
| Annexon Inc | 03589W102 | $41K | 0.80 | 7,048 | EC | US |
| Alto Neuroscience Inc | 02157Q109 | $40K | 0.78 | 1,571 | EC | US |
| SanBio Company Limited | — | $39K | 0.75 | 3,200 | EC | JP |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | 457985208 | $39K | 0.75 | 3,675 | EC | US |
| Medincell SA | — | $33K | 0.65 | 1,155 | EC | FR |
| LB Pharmaceuticals Inc | 50180M108 | $33K | 0.63 | 1,036 | EC | US |
| Brainsway Ltd | 10501L106 | $31K | 0.60 | 1,869 | OTHER | IL |
| Ceribell Inc | 15678C102 | $27K | 0.52 | 1,337 | EC | US |
| Prothena Corporation PLC | G72800108 | $26K | 0.51 | 2,392 | EC | IE |
| Zylox-Tonbridge Medical Technology Co Ltd | — | $26K | 0.51 | 9,000 | EC | CN |
| Oncolys Biopharma Inc | J61461109 | $25K | 0.49 | 1,400 | EC | JP |
| Relmada Therapeutics Inc | 75955J402 | $25K | 0.48 | 3,334 | EC | US |
| Solid Biosciences Inc | 83422E204 | $24K | 0.46 | 3,302 | EC | US |
| MicroPort NeuroScientific Corp | — | $24K | 0.46 | 18,000 | EC | KY |
| Design Therapeutics Inc | 25056L103 | $24K | 0.46 | 1,744 | EC | US |
| Neuropace Inc | 641288105 | $24K | 0.46 | 1,398 | EC | US |
| Regenxbio Inc | 75901B107 | $23K | 0.44 | 2,532 | EC | US |
| Benitec Biopharma Inc | 08205P209 | $22K | 0.42 | 1,798 | EC | US |
Page 1
of 2
← Previous
Next →
Sector breakdown
Healthcare
80.7%
Other/Unmapped
19.3%
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Aug. 17, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.000645 → -0.000895 (38.8%) |
| Aug. 14, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.00445 → -0.000645 (-85.5%) |
| Aug. 14, 2026 | Increased |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.03521 → 0.0359 (2.0%) |
| Aug. 13, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.01557 → -0.00445 (-71.4%) |
| Aug. 13, 2026 | Trimmed |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.04669 → 0.03521 (-24.6%) |
| Aug. 12, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.01526 → -0.01557 (2.0%) |
| Aug. 12, 2026 | Increased |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.04629 → 0.04669 (0.9%) |
| Aug. 11, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.01551 → -0.01526 (-1.6%) |
| Aug. 10, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.01377 → -0.01551 (12.7%) |
| Aug. 7, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.2549 → -0.01377 (-94.6%) |
| Aug. 7, 2026 | Trimmed |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.2869 → 0.04629 (-83.9%) |
| Aug. 6, 2026 | Exited |
ETD_USD
X92a7be9aa93
|
Position exited — was 0 units/share |
| Aug. 6, 2026 | Increased |
KRW — KRW CASH
X544a66fbeff
|
Units/share: -316.5 → 7.148 (-102.3%) |
| Aug. 6, 2026 | Exited |
KRW
Xc91cfbf2487
|
Position exited — was 316.2 units/share |
| Aug. 6, 2026 | New |
SGAFT — CASH COLLATERAL USD SGAFT
Xe4f63973721
|
New position — 0.01 units/share |
| Aug. 6, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: 0.2385 → -0.2549 (-206.9%) |
| Aug. 6, 2026 | Increased |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.03064 → 0.2869 (836.6%) |
| Aug. 5, 2026 | Trimmed |
2172 — MICROPORT NEUROTECH CORP
KYG6083E1098
|
Units/share: 0.1667 → 0.125 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
2190 — ZYLOX-TONBRIDGE MEDICAL TECH H
CNE100004JD2
|
Units/share: 0.07 → 0.0525 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
317450 — MYUNG IN PHARM LTD
KR7317450005
|
Units/share: 0.00188 → 0.00141 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
326030 — SK BIOPHARMACEUTICALS LTD
KR7326030004
|
Units/share: 0.0204 → 0.0153 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
4588 — ONCOLYS BIOPHARMA INC
JP3202170001
|
Units/share: 0.014 → 0.0105 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
4592 — SANBIO LTD
JP3336750009
|
Units/share: 0.03 → 0.0225 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
9996 — PEIJIA MEDICAL LTD
KYG6981F1090
|
Units/share: 0.2467 → 0.185 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ABOS — ACUMEN PHARMACEUTICALS INC
00509G209
|
Units/share: 0.03349 → 0.02512 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
Units/share: 0.08843 → 0.06633 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ACIU — AC IMMUNE SA
CH0329023102
|
Units/share: 0.03363 → 0.02522 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ALEC — ALECTOR
014442107
|
Units/share: 0.04233 → 0.03175 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ALKS — ALKERMES
IE00B56GVS15
|
Units/share: 0.0458 → 0.03435 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ANNX — ANNEXON
03589W102
|
Units/share: 0.07449 → 0.05587 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
Units/share: 0.01641 → 0.01231 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ARGX — ARGENX SE ADR
04016X101
|
Units/share: 0.0022 → 0.00165 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
Units/share: 0.02681 → 0.02011 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
AUD — AUD CASH
X7660509e216
|
Units/share: 0.00044 → 0.00033 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
Units/share: 0.04749 → 0.03562 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
AXGN — AXOGEN
05463X106
|
Units/share: 0.02703 → 0.02027 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
AXSM — AXSOME THERAPEUTICS
05464T104
|
Units/share: 0.008433 → 0.006325 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
BHVN — BIOHAVEN
VGG1110E1079
|
Units/share: 0.06557 → 0.04918 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
BIIB — BIOGEN
09062X103
|
Units/share: 0.01003 → 0.007525 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
BIOA B — BIOARCTIC CLASS B
SE0010323311
|
Units/share: 0.02227 → 0.01671 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
BNTC — BENITEC BIOPHARMA INC
08205P209
|
Units/share: 0.01761 → 0.01321 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
BWAY — BRAINSWAY ADR REPRESENTING LTD
10501L106
|
Units/share: 0.01532 → 0.01149 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
CAPR — CAPRICOR THERAPEUTICS
14070B309
|
Units/share: 0.02735 → 0.02051 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
CBLL — CERIBELL
15678C102
|
Units/share: 0.01286 → 0.009645 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
CGTX — COGNITION THERAPEUTICS INC
19243B102
|
Units/share: 0.04038 → 0.03029 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
CHF — CHF CASH
X03b61a669e9
|
Units/share: 0.0007333 → 0.00055 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
CLPT — CLEARPOINT NEURO INC
18507C103
|
Units/share: 0.01397 → 0.01048 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DKK — DKK CASH
X6691625ef9e
|
Units/share: 0.00924 → 0.00693 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DNLI — DENALI THERAPEUTICS
24823R105
|
Units/share: 0.07777 → 0.05833 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DNTH — DIANTHUS THERAPEUTICS INC
252828108
|
Units/share: 0.02435 → 0.01826 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DRUG — BRIGHT MINDS BIOSCIENCES
10919W405
|
Units/share: 0.003953 → 0.002965 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DSGN — DESIGN THERAPEUTICS
25056L103
|
Units/share: 0.01969 → 0.01477 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DYN — DYNE THERAPEUTICS
26818M108
|
Units/share: 0.06901 → 0.05176 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
DYVOX — DYNAVOX GROUP
SE0017105620
|
Units/share: 0.05171 → 0.03879 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
EUR — EUR CASH
Xa9e45b2a778
|
Units/share: 0.001693 → 0.00127 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
EWTX — EDGEWISE THERAPEUTICS INC
28036F105
|
Units/share: 0.04102 → 0.03077 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
HKD — HKD CASH
X46f6feb14bc
|
Units/share: 0.06171 → 0.04629 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
HLUN B — H. LUNDBECK CLASS B
DK0061804770
|
Units/share: 0.14 → 0.105 (-25.0%) |
| Aug. 5, 2026 | New |
HWRU6 — MICRO E-MINI RUSSELL 2000 SEP 26
Xa4d4cacf5df
|
New position — 0.000005 units/share |
| Aug. 5, 2026 | Trimmed |
IART — INTEGRA LIFESCIENCES HOLDINGS
457985208
|
Units/share: 0.0348 → 0.0261 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
IDIA — IDORSIA N LTD
CH0363463438
|
Units/share: 0.09265 → 0.06949 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
IKT — INHIBIKASE THERAPEUTICS
45719W205
|
Units/share: 0.05048 → 0.03786 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
JPY — JPY CASH
Xbcc3be1cd91
|
Units/share: 0.09691 → 0.07269 (-25.0%) |
| Aug. 5, 2026 | Increased |
KRW — KRW CASH
X544a66fbeff
|
Units/share: -422 → -316.5 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
KRW
Xc91cfbf2487
|
Units/share: 421.5 → 316.2 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
LBRX — LB PHARMACEUTICALS INC
50180M108
|
Units/share: 0.01085 → 0.00814 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
LRMR — LARIMAR THERAPEUTICS
517125100
|
Units/share: 0.02673 → 0.02005 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
MEDCL — MEDINCELL SA
FR0004065605
|
Units/share: 0.01219 → 0.009145 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
MPLT — MAPLIGHT THERAPEUTICS
56565P103
|
Units/share: 0.003953 → 0.002965 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NBIX — NEUROCRINE BIOSCIENCES
64125C109
|
Units/share: 0.01195 → 0.008965 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NEU — NEUREN PHARMACEUTICALS
NZNEUE0001S8
|
Units/share: 0.0572 → 0.0429 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NGNE — NEUROGENE INC
64135M105
|
Units/share: 0.006573 → 0.00493 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NMRA — NEUMORA THERAPEUTICS INC
640979100
|
Units/share: 0.039 → 0.02925 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NPCE — NEUROPACE
641288105
|
Units/share: 0.01371 → 0.01029 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
NWRN — NEWRON PHARMACEUTICALS
IT0004147952
|
Units/share: 0.00942 → 0.007065 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
OVID — OVID THERAPEUTICS
690469101
|
Units/share: 0.08691 → 0.06518 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
PEPG — PEPGEN
713317105
|
Units/share: 0.03089 → 0.02317 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
PRAX — PRAXIS PRECISION MEDICINES
74006W207
|
Units/share: 0.007713 → 0.005785 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
PRTA — PROTHENA PLC
IE00B91XRN20
|
Units/share: 0.02452 → 0.01839 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
PTCT — PTC THERAPEUTICS
69366J200
|
Units/share: 0.02763 → 0.02073 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
RAPP — RAPPORT THERAPEUTICS
75383L102
|
Units/share: 0.01487 → 0.01115 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
RGNX — REGENXBIO
75901B107
|
Units/share: 0.02443 → 0.01833 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
RLMD — RELMADA THERAPEUTICS INC
75955J402
|
Units/share: 0.04814 → 0.03611 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SANN — SANTHERA N AG
CH1276028821
|
Units/share: 0.006853 → 0.00514 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SEK — SEK CASH
Xa09e2bcc066
|
Units/share: 0.01162 → 0.008715 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SLDB — SOLID BIOSCIENCES INC
83422E204
|
Units/share: 0.04088 → 0.03066 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SRPT — SAREPTA THERAPEUTICS
803607100
|
Units/share: 0.05292 → 0.03969 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SRRK — SCHOLAR ROCK HOLDING
80706P103
|
Units/share: 0.04425 → 0.03319 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
SUPN — SUPERNUS PHARMACEUTICALS
868459108
|
Units/share: 0.02846 → 0.02135 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
TNXP — TONIX PHARMACEUTICALS HOLDING
890260839
|
Units/share: 0.008467 → 0.00635 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
TRDA — ENTRADA THERAPEUTICS
29384C108
|
Units/share: 0.0118 → 0.00885 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
TSHA — TAYSHA GENE THERAPIES
877619106
|
Units/share: 0.1244 → 0.09333 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: 0.3232 → 0.2385 (-26.2%) |
| Aug. 5, 2026 | Trimmed |
VNDA — VANDA PHARMACEUTICALS INC
921659108
|
Units/share: 0.02971 → 0.02228 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
VYGR — VOYAGER THERAPEUTICS
92915B106
|
Units/share: 0.02737 → 0.02053 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
XENE — XENON PHARMACEUTICALS
98420N105
|
Units/share: 0.0379 → 0.02843 (-25.0%) |
| Aug. 5, 2026 | Trimmed |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.04085 → 0.03064 (-25.0%) |
| Aug. 4, 2026 | Increased |
2172 — MICROPORT NEUROTECH CORP
KYG6083E1098
|
Units/share: 0.1267 → 0.1667 (31.6%) |
| Aug. 4, 2026 | Increased |
2190 — ZYLOX-TONBRIDGE MEDICAL TECH H
CNE100004JD2
|
Units/share: 0.05333 → 0.07 (31.3%) |
| Aug. 4, 2026 | Increased |
317450 — MYUNG IN PHARM LTD
KR7317450005
|
Units/share: 0.001413 → 0.00188 (33.0%) |
| Aug. 4, 2026 | Increased |
326030 — SK BIOPHARMACEUTICALS LTD
KR7326030004
|
Units/share: 0.0153 → 0.0204 (33.3%) |
| Aug. 4, 2026 | Increased |
4588 — ONCOLYS BIOPHARMA INC
JP3202170001
|
Units/share: 0.01067 → 0.014 (31.3%) |
| Aug. 4, 2026 | Increased |
4592 — SANBIO LTD
JP3336750009
|
Units/share: 0.02267 → 0.03 (32.4%) |
| Aug. 4, 2026 | Increased |
9996 — PEIJIA MEDICAL LTD
KYG6981F1090
|
Units/share: 0.1867 → 0.2467 (32.1%) |
| Aug. 4, 2026 | Increased |
ABOS — ACUMEN PHARMACEUTICALS INC
00509G209
|
Units/share: 0.02512 → 0.03349 (33.3%) |
| Aug. 4, 2026 | Increased |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
Units/share: 0.06633 → 0.08843 (33.3%) |
| Aug. 4, 2026 | Increased |
ACIU — AC IMMUNE SA
CH0329023102
|
Units/share: 0.02522 → 0.03363 (33.3%) |
| Aug. 4, 2026 | Increased |
ALEC — ALECTOR
014442107
|
Units/share: 0.03175 → 0.04233 (33.3%) |
| Aug. 4, 2026 | Increased |
ALKS — ALKERMES
IE00B56GVS15
|
Units/share: 0.03435 → 0.0458 (33.3%) |
| Aug. 4, 2026 | Increased |
ANNX — ANNEXON
03589W102
|
Units/share: 0.05587 → 0.07449 (33.3%) |
| Aug. 4, 2026 | Increased |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
Units/share: 0.01231 → 0.01641 (33.3%) |
| Aug. 4, 2026 | Increased |
ARGX — ARGENX SE ADR
04016X101
|
Units/share: 0.001653 → 0.0022 (33.1%) |
| Aug. 4, 2026 | Increased |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
Units/share: 0.02011 → 0.02681 (33.3%) |
| Aug. 4, 2026 | Increased |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
Units/share: 0.03562 → 0.04749 (33.3%) |
| Aug. 4, 2026 | Increased |
AXGN — AXOGEN
05463X106
|
Units/share: 0.02027 → 0.02703 (33.3%) |
| Aug. 4, 2026 | Increased |
AXSM — AXSOME THERAPEUTICS
05464T104
|
Units/share: 0.006327 → 0.008433 (33.3%) |
| Aug. 4, 2026 | Increased |
BHVN — BIOHAVEN
VGG1110E1079
|
Units/share: 0.04918 → 0.06557 (33.3%) |
| Aug. 4, 2026 | Increased |
BIIB — BIOGEN
09062X103
|
Units/share: 0.007527 → 0.01003 (33.3%) |
| Aug. 4, 2026 | Increased |
BIOA B — BIOARCTIC CLASS B
SE0010323311
|
Units/share: 0.01671 → 0.02227 (33.3%) |
| Aug. 4, 2026 | Increased |
BNTC — BENITEC BIOPHARMA INC
08205P209
|
Units/share: 0.01321 → 0.01761 (33.3%) |
| Aug. 4, 2026 | Increased |
BWAY — BRAINSWAY ADR REPRESENTING LTD
10501L106
|
Units/share: 0.01149 → 0.01532 (33.3%) |
| Aug. 4, 2026 | Increased |
CAPR — CAPRICOR THERAPEUTICS
14070B309
|
Units/share: 0.02051 → 0.02735 (33.3%) |
| Aug. 4, 2026 | Increased |
CBLL — CERIBELL
15678C102
|
Units/share: 0.009647 → 0.01286 (33.3%) |
| Aug. 4, 2026 | Increased |
CGTX — COGNITION THERAPEUTICS INC
19243B102
|
Units/share: 0.03029 → 0.04038 (33.3%) |
| Aug. 4, 2026 | Increased |
CLPT — CLEARPOINT NEURO INC
18507C103
|
Units/share: 0.01048 → 0.01397 (33.3%) |
| Aug. 4, 2026 | Increased |
DNLI — DENALI THERAPEUTICS
24823R105
|
Units/share: 0.05833 → 0.07777 (33.3%) |
| Aug. 4, 2026 | Increased |
DNTH — DIANTHUS THERAPEUTICS INC
252828108
|
Units/share: 0.01826 → 0.02435 (33.3%) |
| Aug. 4, 2026 | Increased |
DRUG — BRIGHT MINDS BIOSCIENCES
10919W405
|
Units/share: 0.002967 → 0.003953 (33.3%) |
| Aug. 4, 2026 | Increased |
DSGN — DESIGN THERAPEUTICS
25056L103
|
Units/share: 0.01477 → 0.01969 (33.3%) |
| Aug. 4, 2026 | Increased |
DYN — DYNE THERAPEUTICS
26818M108
|
Units/share: 0.05176 → 0.06901 (33.3%) |
| Aug. 4, 2026 | Increased |
DYVOX — DYNAVOX GROUP
SE0017105620
|
Units/share: 0.03879 → 0.05171 (33.3%) |
| Aug. 4, 2026 | Increased |
EWTX — EDGEWISE THERAPEUTICS INC
28036F105
|
Units/share: 0.03077 → 0.04102 (33.3%) |
| Aug. 4, 2026 | Increased |
HLUN B — H. LUNDBECK CLASS B
DK0061804770
|
Units/share: 0.105 → 0.14 (33.3%) |
| Aug. 4, 2026 | Increased |
IART — INTEGRA LIFESCIENCES HOLDINGS
457985208
|
Units/share: 0.0261 → 0.0348 (33.3%) |
| Aug. 4, 2026 | Increased |
IDIA — IDORSIA N LTD
CH0363463438
|
Units/share: 0.06949 → 0.09265 (33.3%) |
| Aug. 4, 2026 | Increased |
IKT — INHIBIKASE THERAPEUTICS
45719W205
|
Units/share: 0.03786 → 0.05048 (33.3%) |
| Aug. 4, 2026 | Trimmed |
KRW — KRW CASH
X544a66fbeff
|
Units/share: 5.466 → -422 (-7820.1%) |
| Aug. 4, 2026 | New |
KRW
Xc91cfbf2487
|
New position — 421.5 units/share |
| Aug. 4, 2026 | Increased |
LBRX — LB PHARMACEUTICALS INC
50180M108
|
Units/share: 0.00814 → 0.01085 (33.3%) |
| Aug. 4, 2026 | Increased |
LRMR — LARIMAR THERAPEUTICS
517125100
|
Units/share: 0.02005 → 0.02673 (33.3%) |
| Aug. 4, 2026 | Increased |
MEDCL — MEDINCELL SA
FR0004065605
|
Units/share: 0.009147 → 0.01219 (33.3%) |
| Aug. 4, 2026 | Increased |
MPLT — MAPLIGHT THERAPEUTICS
56565P103
|
Units/share: 0.002967 → 0.003953 (33.3%) |
| Aug. 4, 2026 | Increased |
NBIX — NEUROCRINE BIOSCIENCES
64125C109
|
Units/share: 0.008967 → 0.01195 (33.3%) |
| Aug. 4, 2026 | Increased |
NEU — NEUREN PHARMACEUTICALS
NZNEUE0001S8
|
Units/share: 0.0429 → 0.0572 (33.3%) |
| Aug. 4, 2026 | Increased |
NGNE — NEUROGENE INC
64135M105
|
Units/share: 0.004933 → 0.006573 (33.2%) |
| Aug. 4, 2026 | Increased |
NMRA — NEUMORA THERAPEUTICS INC
640979100
|
Units/share: 0.02925 → 0.039 (33.3%) |
| Aug. 4, 2026 | Increased |
NPCE — NEUROPACE
641288105
|
Units/share: 0.01029 → 0.01371 (33.3%) |
| Aug. 4, 2026 | Increased |
NWRN — NEWRON PHARMACEUTICALS
IT0004147952
|
Units/share: 0.007067 → 0.00942 (33.3%) |
| Aug. 4, 2026 | Increased |
OVID — OVID THERAPEUTICS
690469101
|
Units/share: 0.06518 → 0.08691 (33.3%) |
| Aug. 4, 2026 | Increased |
PEPG — PEPGEN
713317105
|
Units/share: 0.02317 → 0.03089 (33.3%) |
| Aug. 4, 2026 | Increased |
PRAX — PRAXIS PRECISION MEDICINES
74006W207
|
Units/share: 0.005787 → 0.007713 (33.3%) |
| Aug. 4, 2026 | Increased |
PRTA — PROTHENA PLC
IE00B91XRN20
|
Units/share: 0.01839 → 0.02452 (33.3%) |
| Aug. 4, 2026 | Increased |
PTCT — PTC THERAPEUTICS
69366J200
|
Units/share: 0.02073 → 0.02763 (33.3%) |
| Aug. 4, 2026 | Increased |
RAPP — RAPPORT THERAPEUTICS
75383L102
|
Units/share: 0.01115 → 0.01487 (33.3%) |
| Aug. 4, 2026 | Increased |
RGNX — REGENXBIO
75901B107
|
Units/share: 0.01833 → 0.02443 (33.3%) |
| Aug. 4, 2026 | Increased |
RLMD — RELMADA THERAPEUTICS INC
75955J402
|
Units/share: 0.03611 → 0.04814 (33.3%) |
| Aug. 4, 2026 | Increased |
SANN — SANTHERA N AG
CH1276028821
|
Units/share: 0.00514 → 0.006853 (33.3%) |
| Aug. 4, 2026 | Increased |
SLDB — SOLID BIOSCIENCES INC
83422E204
|
Units/share: 0.03066 → 0.04088 (33.3%) |
| Aug. 4, 2026 | Increased |
SRPT — SAREPTA THERAPEUTICS
803607100
|
Units/share: 0.03969 → 0.05292 (33.3%) |
| Aug. 4, 2026 | Increased |
SRRK — SCHOLAR ROCK HOLDING
80706P103
|
Units/share: 0.03319 → 0.04425 (33.3%) |
| Aug. 4, 2026 | Increased |
SUPN — SUPERNUS PHARMACEUTICALS
868459108
|
Units/share: 0.02135 → 0.02846 (33.3%) |
| Aug. 4, 2026 | Increased |
TNXP — TONIX PHARMACEUTICALS HOLDING
890260839
|
Units/share: 0.006353 → 0.008467 (33.3%) |
| Aug. 4, 2026 | Increased |
TRDA — ENTRADA THERAPEUTICS
29384C108
|
Units/share: 0.008853 → 0.0118 (33.3%) |
| Aug. 4, 2026 | Increased |
TSHA — TAYSHA GENE THERAPIES
877619106
|
Units/share: 0.09333 → 0.1244 (33.3%) |
| Aug. 4, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.008907 → 0.3232 (-3729.2%) |
| Aug. 4, 2026 | Increased |
VNDA — VANDA PHARMACEUTICALS INC
921659108
|
Units/share: 0.02228 → 0.02971 (33.3%) |
| Aug. 4, 2026 | Increased |
VYGR — VOYAGER THERAPEUTICS
92915B106
|
Units/share: 0.02053 → 0.02737 (33.3%) |
| Aug. 4, 2026 | Increased |
XENE — XENON PHARMACEUTICALS
98420N105
|
Units/share: 0.02843 → 0.0379 (33.3%) |
| Aug. 4, 2026 | Increased |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 0.03965 → 0.04085 (3.0%) |
| Aug. 3, 2026 | Trimmed |
CHF — CHF CASH
X03b61a669e9
|
Units/share: 0.00074 → 0.0007333 (-0.9%) |
| July 31, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.008607 → -0.008907 (3.5%) |
| July 30, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.008073 → -0.008607 (6.6%) |
| July 29, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.008107 → -0.008073 (-0.4%) |
| July 28, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.006827 → -0.008107 (18.7%) |
| July 24, 2026 | Trimmed |
USD — USD CASH
X2f5743ed867
|
Units/share: -0.0062 → -0.006827 (10.1%) |
| July 23, 2026 | Increased |
USD — USD CASH
X2f5743ed867
|
Units/share: -1.337 → -0.0062 (-99.5%) |
| July 23, 2026 | Trimmed |
XTSLA — BLK CSH FND TREASURY SL AGENCY
066922477
|
Units/share: 1.372 → 0.03965 (-97.1%) |
| July 17, 2026 | New |
2172 — MICROPORT NEUROTECH CORP
KYG6083E1098
|
New position — 0.1267 units/share |
| July 17, 2026 | New |
2190 — ZYLOX-TONBRIDGE MEDICAL TECH H
CNE100004JD2
|
New position — 0.05333 units/share |
| July 17, 2026 | New |
317450 — MYUNG IN PHARM LTD
KR7317450005
|
New position — 0.001413 units/share |
| July 17, 2026 | New |
326030 — SK BIOPHARMACEUTICALS LTD
KR7326030004
|
New position — 0.0153 units/share |
| July 17, 2026 | New |
4588 — ONCOLYS BIOPHARMA INC
JP3202170001
|
New position — 0.01067 units/share |
| July 17, 2026 | New |
4592 — SANBIO LTD
JP3336750009
|
New position — 0.02267 units/share |
| July 17, 2026 | New |
9996 — PEIJIA MEDICAL LTD
KYG6981F1090
|
New position — 0.1867 units/share |
| July 17, 2026 | New |
ABOS — ACUMEN PHARMACEUTICALS INC
00509G209
|
New position — 0.02512 units/share |
| July 17, 2026 | New |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
New position — 0.06633 units/share |
| July 17, 2026 | New |
ACIU — AC IMMUNE SA
CH0329023102
|
New position — 0.02522 units/share |
| July 17, 2026 | New |
ALEC — ALECTOR
014442107
|
New position — 0.03175 units/share |
| July 17, 2026 | New |
ALKS — ALKERMES
IE00B56GVS15
|
New position — 0.03435 units/share |
| July 17, 2026 | New |
ANNX — ANNEXON
03589W102
|
New position — 0.05587 units/share |
| July 17, 2026 | New |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
New position — 0.01231 units/share |
| July 17, 2026 | New |
ARGX — ARGENX SE ADR
04016X101
|
New position — 0.001653 units/share |
| July 17, 2026 | New |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
New position — 0.02011 units/share |
| July 17, 2026 | New |
AUD — AUD CASH
X7660509e216
|
New position — 0.00044 units/share |
| July 17, 2026 | New |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
New position — 0.03562 units/share |
| July 17, 2026 | New |
AXGN — AXOGEN
05463X106
|
New position — 0.02027 units/share |
| July 17, 2026 | New |
AXSM — AXSOME THERAPEUTICS
05464T104
|
New position — 0.006327 units/share |
| July 17, 2026 | New |
BHVN — BIOHAVEN
VGG1110E1079
|
New position — 0.04918 units/share |
| July 17, 2026 | New |
BIIB — BIOGEN
09062X103
|
New position — 0.007527 units/share |
| July 17, 2026 | New |
BIOA B — BIOARCTIC CLASS B
SE0010323311
|
New position — 0.01671 units/share |
Showing latest 200 of 256 changes
Institutional owners (13F) 7 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | $825,331 | 53.84% | 21,257 | Shares | June 30, 2026 |
| BlackRock, Inc. | $582,395 | 37.99% | 15,000 | Shares | June 30, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $104,831 | 6.84% | 2,700 | Shares | June 30, 2026 |
| UBS Group AG | $7,726 | 0.50% | 199 | Shares | June 30, 2026 |
| CWM, LLC | $5,372 | 0.35% | 163 | Shares | March 31, 2026 |
| ASSETMARK, INC | $3,883 | 0.25% | 100 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $3,421 | 0.22% | 88 | Shares | June 30, 2026 |
Peer funds
More from this issuer
Similar by size
| Fund | AUM |
|---|---|
| PANG Themes ETF Trust | $5.2M |
| AGRH iShares U.S. ETF Trust | $5.2M |
| RXD ProShares Trust | $5.3M |
| MAKX ProShares Trust | $5.3M |
| TEXU Direxion Shares ETF Trust | $5.4M |
| PMAP PGIM Rock ETF Trust | $5.1M |
| CHRI Global X Funds | $5.1M |
| RNTY Tidal Trust II | $5.1M |
| DISO Tidal Trust II | $5.0M |
| NFXS Direxion Shares ETF Trust | $5.0M |